Abstract

Non-ribosomal peptide synthetases are important enzymes for the assembly of complex peptide natural products. Within these multi-modular assembly lines, condensation domains perform the central function of chain assembly, typically by forming a peptide bond between two peptidyl carrier protein (PCP)-bound substrates. In this work, we report structural snapshots of a condensation domain in complex with an aminoacyl-PCP acceptor substrate. These structures allow the identification of a mechanism that controls access of acceptor substrates to the active site in condensation domains. The structures of this complex also allow us to demonstrate that condensation domain active sites do not contain a distinct pocket to select the side chain of the acceptor substrate during peptide assembly but that residues within the active site motif can instead serve to tune the selectivity of these central biosynthetic domains.

Non-ribosomal peptide synthetases (NRPSs) are multi-modular enzymes assembling complex natural products. Here, the structures of a Thermobifida fusca NRPS condensation domain bound to the substrate-bearing peptidyl carrier protein (PCP) domain provide insight into the mechanisms of substrate selectivity and engagement within the catalytic pocket.

Details

Title
Structures of a non-ribosomal peptide synthetase condensation domain suggest the basis of substrate selectivity
Author
Izoré Thierry 1 ; Candace Ho Y T 2 ; Kaczmarski, Joe A 3   VIAFID ORCID Logo  ; Gavriilidou Athina 4 ; Chow, Ka Ho 5 ; Steer, David L 6 ; Goode Robert J A 6   VIAFID ORCID Logo  ; Schittenhelm, Ralf B 6   VIAFID ORCID Logo  ; Tailhades Julien 7 ; Tosin Manuela 8 ; Challis, Gregory L 9   VIAFID ORCID Logo  ; Krenske, Elizabeth H 5   VIAFID ORCID Logo  ; Ziemert Nadine 10   VIAFID ORCID Logo  ; Jackson, Colin J 11   VIAFID ORCID Logo  ; Cryle, Max J 7   VIAFID ORCID Logo 

 Monash University, Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash University, EMBL Australia, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 Monash University, Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash University, EMBL Australia, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Australia (GRID:grid.1002.3); University of Warwick, Department of Chemistry, Coventry, UK (GRID:grid.7372.1) (ISNI:0000 0000 8809 1613) 
 The Australian National University, Research School of Chemistry, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477) 
 Interfaculty Institute of Microbiology and Infection Medicine Tübingen, Microbiology/Biotechnology, University of Tübingen, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447) 
 The University of Queensland, School of Chemistry and Molecular Biosciences, St Lucia, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
 Monash University, Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash University, Monash Proteomics and Metabolomics Facility, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 Monash University, Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash University, EMBL Australia, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Australia (GRID:grid.1002.3) 
 University of Warwick, Department of Chemistry, Coventry, UK (GRID:grid.7372.1) (ISNI:0000 0000 8809 1613) 
 Monash University, Department of Biochemistry and Molecular Biology, The Monash Biomedicine Discovery Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Australia (GRID:grid.1002.3); University of Warwick, Department of Chemistry, Coventry, UK (GRID:grid.7372.1) (ISNI:0000 0000 8809 1613); University of Warwick, Warwick Integrative Synthetic Biology Centre, Coventry, UK (GRID:grid.7372.1) (ISNI:0000 0000 8809 1613) 
10  German Centre for Infection Research (DZIF), Partnersite Tübingen, Tübingen, Germany (GRID:grid.452463.2); Interfaculty Institute for Biomedical Informatics (IBMI), University of Tübingen, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447) 
11  ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Australia (GRID:grid.10392.39); The Australian National University, Research School of Chemistry, Acton, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2521814598
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.